Literature DB >> 20061129

The role of p53 in glucose metabolism.

Eric C Cheung1, Karen H Vousden.   

Abstract

The p53 protein functions to prevent tumour development by inhibiting the outgrowth of stressed or damaged cells. In addition to well established functions to block cell proliferation, recent studies have revealed a role for p53 in the regulation of pathways involved in glucose metabolism. The metabolic functions of p53 resist the shift to glycolysis that is characteristically seen in cancers, and also help cells adapt to and survive limited periods of metabolic stress. Such activities of p53 would not only help to prevent cancer development, but might also contribute to non-tumour related roles for p53, such as in the regulation of longevity. These new functions of p53 are providing interesting possibilities for the development of novel therapies. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061129     DOI: 10.1016/j.ceb.2009.12.006

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  34 in total

Review 1.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

2.  p53 Protects lung cancer cells against metabolic stress.

Authors:  Chompunoot Sinthupibulyakit; Wanida Ittarat; William H St Clair; Daret K St Clair
Journal:  Int J Oncol       Date:  2010-12       Impact factor: 5.650

3.  Supercompetitor status of Drosophila Myc cells requires p53 as a fitness sensor to reprogram metabolism and promote viability.

Authors:  Claire de la Cova; Nanami Senoo-Matsuda; Marcello Ziosi; D Christine Wu; Paola Bellosta; Catarina M Quinzii; Laura A Johnston
Journal:  Cell Metab       Date:  2014-02-20       Impact factor: 27.287

4.  Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms.

Authors:  Sebastian K-J Landor; Anders P Mutvei; Veronika Mamaeva; Shaobo Jin; Morten Busk; Ronald Borra; Tove J Grönroos; Pauliina Kronqvist; Urban Lendahl; Cecilia Maria Sahlgren
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

5.  Transcriptome profiling identifies p53 as a key player during calreticulin deficiency: Implications in lipid accumulation.

Authors:  Saurabh Vig; Puneet Talwar; Kirandeep Kaur; Rohit Srivastava; Arvind K Srivastava; Malabika Datta
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

Review 6.  Glycolytic genes in cancer cells are more than glucose metabolic regulators.

Authors:  Zhe-Yu Hu; Lanbo Xiao; Ann M Bode; Zigang Dong; Ya Cao
Journal:  J Mol Med (Berl)       Date:  2014-06-08       Impact factor: 4.599

Review 7.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

Review 8.  Autophagy-mediated tumor promotion.

Authors:  Jessie Yanxiang Guo; Bing Xia; Eileen White
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

9.  Overexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase II from mitochondrial outer membrane.

Authors:  Sujie Gao; Xuebo Chen; Hongyong Jin; Shengnan Ren; Zhuo Liu; Xuedong Fang; Guizhen Zhang
Journal:  Oncol Lett       Date:  2015-12-21       Impact factor: 2.967

10.  The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target.

Authors:  Lu-Zhe Pan; Dae-Gyun Ahn; Tanveer Sharif; Derek Clements; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.